AMRA Medical and Fulcrum Therapeutics Develop MRI Method for Multi-site Neuromuscular Clinical Trials |
April 03, 2020 | April 2020 Bond Updates |
LINKÖPING, Sweden, April 2, 2020 /PRNewswire/ -- In collaboration, AMRA Medical and Fulcrum Therapeutics created a standardized whole-body magnetic resonance imaging (MRI) protocol to evaluate skeletal muscle composition in patients with facioscapulohumeral dystrophy (FSHD) – a slowly... |
View more at: https://www.prnewswire.com:443/news-releases/amra-medical-and-fulcrum-therapeutics-develop-mri-method-for-multi-site-neuromuscular-clinical-trials-301034146.html |
Related News |
|